|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 JPY | +1.25% |
|
+2.75% | +1.57% |
| Capitalization | 234B 1.47B 1.26B 1.18B 1.1B 2.04B 133B 2.2B 13.55B 5.32B 63.48B 5.52B 5.4B | P/E ratio 2026 * |
9.36x | P/E ratio 2027 * | 9.04x |
|---|---|---|---|---|---|
| Enterprise value | 234B 1.47B 1.26B 1.18B 1.1B 2.04B 133B 2.2B 13.55B 5.32B 63.48B 5.52B 5.4B | EV / Sales 2026 * |
0.94x | EV / Sales 2027 * | 0.86x |
| Free-Float |
60.43% | Yield 2026 * |
2.67% | Yield 2027 * | 2.66% |
| 1 day | +1.25% | ||
| 1 week | +2.75% | ||
| Current month | +1.57% | ||
| 1 month | +0.73% | ||
| 3 months | +2.21% | ||
| 6 months | +5.54% | ||
| Current year | +1.57% |
| 1 week | 4,750 |  | 4,895 |
| 1 month | 4,710 | | 4,915 |
| Current year | 4,710 | | 4,895 |
| 1 year | 3,470 | | 5,240 |
| 3 years | 2,393 | | 5,240 |
| 5 years | 2,181 | | 5,240 |
| 10 years | 1,661 | | 5,240 |
| Manager | Title | Age | Since |
|---|---|---|---|
Genji Ishida
DFI | Director of Finance/CFO | 54 | 2016-03-31 |
| President | 45 | 2024-06-30 | |
| Director of Finance/CFO | 59 | 2011-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Kazuo Isozaki
BRD | Director/Board Member | 62 | 2004-05-31 |
Hideyuki Naoi
BRD | Director/Board Member | 63 | 2002-05-31 |
Manabu Nakamatsu
BRD | Director/Board Member | 64 | 2010-05-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.89% | 0.76% | 12 M€ | |
| +4.70% | 0.05% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.25% | +2.75% | +35.75% | +96.21% | 1.46B | |
| -1.21% | -1.32% | +33.30% | +91.28% | 48.87B | |
| -3.51% | -1.96% | +4.03% | -13.33% | 20.49B | |
| +0.98% | +2.91% | -0.46% | +60.55% | 16.44B | |
| -1.36% | -1.39% | +45.24% | +95.12% | 16.54B | |
| +0.34% | +7.33% | +18.62% | -22.69% | 11.33B | |
| -1.01% | -1.32% | +8.37% | +50.87% | 7.44B | |
| -2.17% | +1.71% | -13.65% | +16.82% | 7.34B | |
| +0.50% | +4.39% | -16.05% | +54.41% | 4.29B | |
| +2.29% | +1.61% | +44.07% | +22.13% | 3.94B | |
| Average | -0.39% | +2.56% | +15.92% | +45.14% | 13.81B | |
| Weighted average by Cap. | -1.04% | +2.32% | +20.13% | +54.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 250B 1.57B 1.35B 1.26B 1.17B 2.18B 142B 2.35B 14.47B 5.69B 67.79B 5.89B 5.77B | 274B 1.72B 1.48B 1.38B 1.28B 2.39B 155B 2.57B 15.83B 6.22B 74.16B 6.44B 6.31B |
| Net income | 25B 157M 135M 126M 117M 218M 14.18B 235M 1.45B 569M 6.78B 589M 577M | 25.9B 163M 140M 130M 121M 226M 14.7B 244M 1.5B 589M 7.02B 610M 598M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-13 | 4,860.00 ¥ | +1.25% | 75,500 |
| 26-01-09 | 4,800.00 ¥ | +0.42% | 52,300 |
| 26-01-08 | 4,780.00 ¥ | -0.31% | 70,900 |
| 26-01-07 | 4,795.00 ¥ | -1.24% | 61,200 |
| 26-01-06 | 4,855.00 ¥ | +2.64% | 102,300 |
Delayed Quote Japan Exchange, January 13, 2026 at 01:30 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 8850 Stock
Select your edition
All financial news and data tailored to specific country editions
